107600 — Sebitchem Co Balance Sheet
0.000.00%
- KR₩223bn
- KR₩224bn
- KR₩46bn
Annual balance sheet for Sebitchem Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | KAS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 695 | 2,802 | 5,455 | 51,151 | 39,939 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,072 | 2,319 | 4,177 | 7,425 | 5,049 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,526 | 7,819 | 13,507 | 69,588 | 50,923 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,572 | 8,829 | 9,911 | 18,456 | 43,173 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 12,218 | 16,799 | 23,886 | 89,592 | 98,598 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,577 | 5,676 | 6,708 | 10,980 | 19,166 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 5,117 | 6,715 | 9,239 | 26,447 | 35,528 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 7,101 | 10,084 | 14,646 | 63,145 | 63,070 |
Total Liabilities & Shareholders' Equity | 12,218 | 16,799 | 23,886 | 89,592 | 98,598 |
Total Common Shares Outstanding |